Neurogene Inc.
NGNE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $367 | $315 | $246 | $340 |
| - Cash | $71 | $59 | $71 | $137 |
| + Debt | $10 | $11 | $14 | $12 |
| Enterprise Value | $306 | $267 | $189 | $215 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$15 |
| % Margin | – | – | – | – |
| EBITDA | -$20 | -$21 | -$22 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$21 | -$22 | -$23 | -$20 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.99 | -1.05 | -1.08 | -1.31 |
| % Growth | 5.7% | 2.8% | 17.6% | – |
| Operating Cash Flow | -$20 | -$19 | -$21 | -$17 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$20 | -$20 | -$22 | -$18 |